Emanuele Garzia, Valentina Galiano, Paolo Pasquale Guarnerio, Anna Maria Marconi
{"title":"Diagnostic pitfalls in ovarian androgen-secreting tumors in postmenopausal women with rapidly progressed severe hyperandrogenism.","authors":"Emanuele Garzia, Valentina Galiano, Paolo Pasquale Guarnerio, Anna Maria Marconi","doi":"10.1177/20533691241304541","DOIUrl":null,"url":null,"abstract":"<p><p>ObjectiveSex cord-stromal neoplasms of the ovary are rare tumors and a very infrequent cause of androgen excess and virilization in women. We report two cases of postmenopausal women with rapidly progressive signs of virilization and negative or indeterminate imaging for pelvic masses.MethodsBoth patients underwent a complete hormone profile, inconclusive transvaginal ultrasound and contrast-enhanced abdominopelvic computed tomography.ResultsSerum hormone analysis revealed for both cases a marked increase in serum total testosterone (T). In the first woman, Δ-4 androstenedione (Δ-4 A), dehydroepiandrosterone-sulfate (DHEA-S) and cortisol levels were in a normal range for age. In the second, Δ-4 A and DHEA-S levels were below the reference range. For both women, an ovarian source of androgens was suspected and bilateral laparoscopic oophorectomy was performed. Ovarian histology demostrated bilateral Leydig cell tumor (LCT) in the first case and bilateral ovarian thecoma in the second. After surgery, total testosterone returned to normal levels and clinical symptoms subsided.ConclusionsIn cases of postmenopausal androgen excess, physicians must rule out relatively rare androgen-producing tumors originating from the adrenals or ovaries. Regardless of imaging evaluation, our report highlights the importance of prompt and careful clinical and hormonal evaluation to ensure appropriate and timely treatment for the patient.</p>","PeriodicalId":52104,"journal":{"name":"Post reproductive health","volume":" ","pages":"45-49"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Post reproductive health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20533691241304541","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/28 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
ObjectiveSex cord-stromal neoplasms of the ovary are rare tumors and a very infrequent cause of androgen excess and virilization in women. We report two cases of postmenopausal women with rapidly progressive signs of virilization and negative or indeterminate imaging for pelvic masses.MethodsBoth patients underwent a complete hormone profile, inconclusive transvaginal ultrasound and contrast-enhanced abdominopelvic computed tomography.ResultsSerum hormone analysis revealed for both cases a marked increase in serum total testosterone (T). In the first woman, Δ-4 androstenedione (Δ-4 A), dehydroepiandrosterone-sulfate (DHEA-S) and cortisol levels were in a normal range for age. In the second, Δ-4 A and DHEA-S levels were below the reference range. For both women, an ovarian source of androgens was suspected and bilateral laparoscopic oophorectomy was performed. Ovarian histology demostrated bilateral Leydig cell tumor (LCT) in the first case and bilateral ovarian thecoma in the second. After surgery, total testosterone returned to normal levels and clinical symptoms subsided.ConclusionsIn cases of postmenopausal androgen excess, physicians must rule out relatively rare androgen-producing tumors originating from the adrenals or ovaries. Regardless of imaging evaluation, our report highlights the importance of prompt and careful clinical and hormonal evaluation to ensure appropriate and timely treatment for the patient.
期刊介绍:
Post Reproductive Health (formerly Menopause International) is a MEDLINE indexed, peer reviewed source of news, research and opinion. Aimed at all those involved in the field of post reproductive health study and treatment, it is a vital resource for all practitioners and researchers. As the official journal of the British Menopause Society (BMS), Post Reproductive Health has a broad scope, tackling all the issues in this field, including the current controversies surrounding postmenopausal health and an ageing and expanding female population. Initially this journal will concentrate on the key areas of menopause, sexual health, urogynaecology, metabolic bone disease, cancer diagnosis and treatment, recovering from cancer, cardiovascular disease, cognition, prescribing, use of new hormone therapies, psychology, the science of ageing, sociology, economics, and quality of life. However as a progressive and innovative journal the Editors are always willing to consider other areas relevant to this rapidly expanding area of healthcare.